Rhinostics closes Series A-2 financing round
Automated nasal swab developer Rhinostics has closed a Series A-2 financing round.
Stay updated with breaking news from Covid Apollo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Automated nasal swab developer Rhinostics has closed a Series A-2 financing round.
Funds Will Accelerate Market Penetration and Novel Technology Development to Improve Diagnostic Sample Collection and Processing WorkflowsWALTHAM, Mass.--(BUSINESS WIRE)--#acceleratecovidtesting--Rhinostics Inc., pioneers in bringing efficiencies to sample collection through modernized technologies, announced the fi...
Grand Prize Winners Selected in $6M XPRIZE Rapid Covid Testing Competition to Create Fast, Frequent, Cheap, and Easy-to-Use Solutions Dr. Rick Bright, Ph.D., Immunology and Molecular Pathogenesis Shawna Butler, R.N. M.D.A., Nurse Economist Dr. Charity Dean, CEO and Co-Founder, The Public Health Company Dr. Paul Drain, Associate Professor, Departments of Global Health, Medicine and Epidemiology at the University of Washington Dr. Anita Goel, Physicist and Physician, Chairman and CEO, Nanobiosym Dr. Michael Mina, Physician-Scientist and Assistant Professor, Epidemiology and Immunology and Infec...